Piper Sandler analysts highlighted their top picks for biotechnology for investors amid the rollercoaster seen in the equity ...

Morgan Stanley lowered the firm’s price target on Alnylam (ALNY) to $268 from $284 and keeps an Equal Weight rating on the shares. The firm is ...

In a report released today, Michael Ulz from Morgan Stanley maintained a Hold rating on Alnylam Pharma (ALNY – Research Report), with a price ...

Detailed price information for Ionis Pharmaceuticals (IONS-Q) from The Globe and Mail including charting and trades.

Alnylam (ALNY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in ...

President Trump's potential new tariffs on medicines raise concerns among investors, triggering declines in pharmaceutical ...

We recently published a list of 10 Best Long Term Growth Stocks to Buy According to Billionaires. In this article, we are ...

As per Barclays, the US administration announced numerous executive orders with reforms associated with world trade, ...

Stock analysts at HC Wainwright boosted their Q3 2025 earnings per share (EPS) estimates for shares of Alnylam ...

Over the last 7 days, the United States market has experienced a drop of 9.4%, contributing to a 3.4% decline over the past year, although earnings are forecast to grow by 14% annually. In this ...